Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Chemmedchem
|
August 1, 2015
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases
Matthias Nettekoven, Jean-Michel Adam, Stefanie Bendels, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2013
BACE1 inhibitors: a head group scan on a series of amides
Thomas J Woltering, Wolfgang Wostl, Hans Hilpert, et al.
Journal of Neurology
|
April 12, 2017
The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
Libby Wood, Isabell Cordts, Antonio Atalaia, et al.
The EMBO Journal
|
June 8, 2018
NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS
Najwa Ouali Alami, Christine Schurr, Florian Olde Heuvel, et al.
Journal of Medicinal Chemistry
|
April 18, 2013
β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease
Hans Hilpert, Wolfgang Guba, Thomas J Woltering, et al.
Journal of Medicinal Chemistry
|
March 14, 2008
Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity
Leo Alig, Jochem Alsenz, Mirjana Andjelkovic, et al.
BJC Reports
|
November 8, 2024
Hereditary gastrointestinal polyposis syndromes Rare Disease Collaborative Network consensus statement agreed at the RDCN meeting Birmingham 17th February 2022
Susan Clark, Vicky Cuthill, Jackie Hawkins, et al.
Plos One
|
June 19, 2019
Seasonal adaptations of the hypothalamo-neurohypophyseal system of the dromedary camel
Fatma Zohra Djazouli Alim, Elena V Romanova, Yea-Ling Tay, et al.
Journal of Medicinal Chemistry
|
January 5, 2002
Development of a virtual screening method for identification of "frequent hitters" in compound libraries
Olivier Roche, Petra Schneider, Jochen Zuegge, et al.
Human Molecular Genetics
|
September 24, 2021
High-resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect
Richard J L F Lemmers, Patrick J van der Vliet, David San Leon Granado, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Chemmedchem
|
August 1, 2015
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases
Matthias Nettekoven, Jean-Michel Adam, Stefanie Bendels, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2013
BACE1 inhibitors: a head group scan on a series of amides
Thomas J Woltering, Wolfgang Wostl, Hans Hilpert, et al.
Journal of Neurology
|
April 12, 2017
The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
Libby Wood, Isabell Cordts, Antonio Atalaia, et al.
The EMBO Journal
|
June 8, 2018
NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS
Najwa Ouali Alami, Christine Schurr, Florian Olde Heuvel, et al.
Journal of Medicinal Chemistry
|
April 18, 2013
β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease
Hans Hilpert, Wolfgang Guba, Thomas J Woltering, et al.
Journal of Medicinal Chemistry
|
March 14, 2008
Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity
Leo Alig, Jochem Alsenz, Mirjana Andjelkovic, et al.
BJC Reports
|
November 8, 2024
Hereditary gastrointestinal polyposis syndromes Rare Disease Collaborative Network consensus statement agreed at the RDCN meeting Birmingham 17th February 2022
Susan Clark, Vicky Cuthill, Jackie Hawkins, et al.
Plos One
|
June 19, 2019
Seasonal adaptations of the hypothalamo-neurohypophyseal system of the dromedary camel
Fatma Zohra Djazouli Alim, Elena V Romanova, Yea-Ling Tay, et al.
Journal of Medicinal Chemistry
|
January 5, 2002
Development of a virtual screening method for identification of "frequent hitters" in compound libraries
Olivier Roche, Petra Schneider, Jochen Zuegge, et al.
Human Molecular Genetics
|
September 24, 2021
High-resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect
Richard J L F Lemmers, Patrick J van der Vliet, David San Leon Granado, et al.
Page
of 8